MedTrace Logo

Investigation of the Bioavailability of Marine Based Collagen Peptides in Healthy Subjects

NCT05252962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-12-17

No results posted yet for this study

Summary

The aim of this study is to evaluate the relative bioavailability of Peptan® Type I collagen peptides from different marine origin (different fish sources, production process and molecular weight) in healthy human subjects.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Collagen Peptides

Collagen peptides will be orally administered and pharmacokinetic parameters will be assessed up to 6 hours after study product intake.

Sponsors & Collaborators

  • BioTeSys GmbH

    collaborator OTHER

  • Rousselot BVBA

    lead INDUSTRY

Principal Investigators

  • Nicoletta Virgilio, PhD · RousselotBVBA

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-26
Primary Completion
2022-02-17
Completion
2023-05-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252962 on ClinicalTrials.gov